211 related articles for article (PubMed ID: 22706174)
1. Delayed systemic recurrence of uveal melanoma.
Kolandjian NA; Wei C; Patel SP; Richard JL; Dett T; Papadopoulos NE; Bedikian AY
Am J Clin Oncol; 2013 Oct; 36(5):443-9. PubMed ID: 22706174
[TBL] [Abstract][Full Text] [Related]
2. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
Bedikian AY; Legha SS; Mavligit G; Carrasco CH; Khorana S; Plager C; Papadopoulos N; Benjamin RS
Cancer; 1995 Nov; 76(9):1665-70. PubMed ID: 8635073
[TBL] [Abstract][Full Text] [Related]
3. Survival Rates in Patients After Treatment for Metastasis From Uveal Melanoma.
Lane AM; Kim IK; Gragoudas ES
JAMA Ophthalmol; 2018 Sep; 136(9):981-986. PubMed ID: 29955797
[TBL] [Abstract][Full Text] [Related]
4. Variates of survival in metastatic uveal melanoma.
Rietschel P; Panageas KS; Hanlon C; Patel A; Abramson DH; Chapman PB
J Clin Oncol; 2005 Nov; 23(31):8076-80. PubMed ID: 16258106
[TBL] [Abstract][Full Text] [Related]
5. Uveal melanoma in the first 4 decades of life.
Sagus M; Bedikian AY
South Med J; 2015 Mar; 108(3):158-63. PubMed ID: 25772049
[TBL] [Abstract][Full Text] [Related]
6. Local recurrence after uveal melanoma proton beam therapy: recurrence types and prognostic consequences.
Caujolle JP; Paoli V; Chamorey E; Maschi C; Baillif S; Herault J; Gastaud P; Hannoun-Levi JM
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1218-24. PubMed ID: 23177670
[TBL] [Abstract][Full Text] [Related]
7. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma.
Kim IK; Lane AM; Gragoudas ES
Arch Ophthalmol; 2010 Jul; 128(7):871-5. PubMed ID: 20625048
[TBL] [Abstract][Full Text] [Related]
8. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment.
Eskelin S; Pyrhönen S; Summanen P; Hahka-Kemppinen M; Kivelä T
Ophthalmology; 2000 Aug; 107(8):1443-9. PubMed ID: 10919885
[TBL] [Abstract][Full Text] [Related]
9. A prognostic model and staging for metastatic uveal melanoma.
Eskelin S; Pyrhönen S; Hahka-Kemppinen M; Tuomaala S; Kivelä T
Cancer; 2003 Jan; 97(2):465-75. PubMed ID: 12518371
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Ultrasonography for Surveillance in Patients With Uveal Melanoma.
Choudhary MM; Gupta A; Bena J; Emch T; Singh AD
JAMA Ophthalmol; 2016 Feb; 134(2):174-80. PubMed ID: 26633182
[TBL] [Abstract][Full Text] [Related]
11. Quality of evidence about effectiveness of treatments for metastatic uveal melanoma.
Augsburger JJ; Corrêa ZM; Shaikh AH
Trans Am Ophthalmol Soc; 2008; 106():128-35; discussion 135-7. PubMed ID: 19277228
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and toxicity of transarterial chemoembolization therapy using cisplatin and gelatin sponge in patients with liver metastases from uveal melanoma in an Asian population.
Shibayama Y; Namikawa K; Sone M; Takahashi A; Tsutsumida A; Sugawara S; Arai Y; Aihara Y; Suzuki S; Nakayama J; Imafuku S; Yamazaki N
Int J Clin Oncol; 2017 Jun; 22(3):577-584. PubMed ID: 28144882
[TBL] [Abstract][Full Text] [Related]
13. The Results of Stricter Inclusion Criteria in an Immunomagnetic Detection Study of Micrometastatic Cells in Bone Marrow of Uveal Melanoma Patients - Relevance for Dormancy.
Eide N; Faye RS; Høifødt HK; Sandvik L; Qvale GA; Faber R; Jebsen P; Kvalheim G; Fodstad Ø
Pathol Oncol Res; 2019 Jan; 25(1):255-262. PubMed ID: 29098521
[TBL] [Abstract][Full Text] [Related]
14. Bimodal mortality dynamics for uveal melanoma: a cue for metastasis development traits?
Demicheli R; Fornili M; Biganzoli E
BMC Cancer; 2014 Jun; 14():392. PubMed ID: 24890689
[TBL] [Abstract][Full Text] [Related]
15. Treatment of liver metastases from uveal melanoma: a retrospective single-center analysis.
Yang XY; Xie F; Tao R; Li AJ; Wu MC
Hepatobiliary Pancreat Dis Int; 2013 Dec; 12(6):602-6. PubMed ID: 24322745
[TBL] [Abstract][Full Text] [Related]
16. Noncontiguous tumor recurrence of posterior uveal melanoma after transscleral local resection.
Kim JW; Damato BE; Hiscott P
Arch Ophthalmol; 2002 Dec; 120(12):1659-64. PubMed ID: 12470139
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of treatments for metastatic uveal melanoma.
Augsburger JJ; Corrêa ZM; Shaikh AH
Am J Ophthalmol; 2009 Jul; 148(1):119-27. PubMed ID: 19375060
[TBL] [Abstract][Full Text] [Related]
18. Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation.
Al-Jamal RT; Eskelin S; Pyrhönen S; Kivelä T
Acta Oncol; 2009; 48(3):476-9. PubMed ID: 19031163
[No Abstract] [Full Text] [Related]
19. Survival from uveal melanoma in Western Australia 1981-2005.
Chew AL; Spilsbury K; Isaacs TW
Clin Exp Ophthalmol; 2015 Jul; 43(5):422-8. PubMed ID: 25556534
[TBL] [Abstract][Full Text] [Related]
20. Protracted survival after resection of metastatic uveal melanoma.
Aoyama T; Mastrangelo MJ; Berd D; Nathan FE; Shields CL; Shields JA; Rosato EL; Rosato FE; Sato T
Cancer; 2000 Oct; 89(7):1561-8. PubMed ID: 11013372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
